San Francisco Bay Area biotech stories.
Wednesday, February 16, 2011
2 companies cut deal, take in cash from Index Ventures, Amunix
Versartis Inc. has completed a $21 million second round of funding, the company said Wednesday.
The round was led by New Leaf Venture Partners, which has an office in Menlo Park.
London-based Advent Venture Partners, Geneva-based Index Ventures and Mountain View-based Amunix Inc. also joined in the round.
Versartis raises $21 million in second round
Diartis Pharmaceuticals Inc., a new company in Mountain View, got money from Index Ventures and Amunix Inc. to develop a diabetes drug it bought from Versartis Inc.
Startup Diartis Pharmaceuticals gets money for diabetes drug development
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)